We are live on ! Find out more
ACG

Anchorage Capital Group Portfolio holdings

AUM $436M
1-Year Est. Return 38.51%
This Fund
S&P 500
This Quarter Est. Return
-9.38%
1 Year Est. Return
-38.51%
3 Year Est. Return
-18.86%
5 Year Est. Return
-55.07%
10 Year Est. Return
+90.94%
AUM
$780M
AUM Growth
-$341M
Cap. Flow
-$334M
Cap. Flow %
-42.88%
Top 10 Hldgs %
92.45%
Holding
20
New
Increased
1
Reduced
Closed
1

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$1.6M

Top Sells

Rank Stock Value
1
ZY
Zymergen Inc. Common Stock
ZY
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 20.09%
2 Communication Services 19.67%
3 Technology 19.51%
4 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
S icon
1
SentinelOne
S
$6.71B
$144M 18.46%
9,867,053
FYBR
2
DELISTED
Frontier Communications
FYBR
$140M 17.92%
5,482,812
DNA icon
3
Ginkgo Bioworks
DNA
$517M
$118M 15.14%
1,746,365
+17,406
+1% +$1.6M
SG icon
4
Sweetgreen
SG
$841M
$41.1M 5.27%
4,795,227
ROIV icon
5
Roivant Sciences
ROIV
$24.8B
$38.6M 4.95%
4,832,642
CNSL
6
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$13.7M 1.75%
3,812,892
AMBP icon
7
Ardagh Metal Packaging
AMBP
$2.8B
$6.01M 0.77%
1,250,000
SOUN icon
8
SoundHound AI
SOUN
$2.73B
$5.66M 0.73%
3,197,767
KPLT icon
9
Katapult Holdings
KPLT
$32.8M
$2.51M 0.32%
105,035
AMBP.WS
10
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$548K 0.07%
1,245,385
DNA.WS
11
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$10K ﹤0.01%
50,000
ZY
12
DELISTED
Zymergen Inc. Common Stock
ZY
-758,513
Closed -$2.11M

Similar funds

Anchorage Capital Group's Q4 2022 Portfolio in Review

As of Q4 2022, Anchorage Capital Group held 20 positions worth $780M, down 30% from $1.12B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Anchorage Capital Group withdrew a net $334M in Q4 2022, closing 1 position. Its most notable exit was Zymergen Inc. Common Stock, an estimated $2.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Anchorage Capital Group added an estimated $1.6M to Ginkgo Bioworks.

  • Anchorage Capital Group added most to Ginkgo Bioworks in Q4 2022, an estimated $1.6M increase.
  • Anchorage Capital Group fully exited Zymergen Inc. Common Stock in Q4 2022, selling an estimated $2.11M.
  • Anchorage Capital Group's ten largest holdings make up 92% of its $780M portfolio in Q4 2022.
  • Anchorage Capital Group opened 0 new positions and closed 1 in Q4 2022.
  • Anchorage Capital Group's portfolio value fell 30% quarter-over-quarter to $780M.

Based on Anchorage Capital Group's 13F filing for Q4 2022, filed 14 Feb 2023.